Very interesting interview. I'm glad that I watched it.
From the video
-They have been doing robotic aortic valve replacement since the beginning of the pandemic, so, a little more than 2 years.
- They have done about 50 of them, as of the time of the video.
-100% of the patients survived short term. Of course, having only been performed for a few years no long term data.
-He calls it ultra-minimally invasive, with even a smaller incision than the other minimally invasive options, offering quicker wound recovery time
-As a side note, he does mention that the 5 year outcome data has proven to be worse for TAVR than SAVR for younger low risk patients, making the point that TAVR is probably not a good choice for said low risk patients, in terms of low term mortality. I totally agree with this.
It will be really interesting to see if this robotic procedure becomes more popular.
I'll take a shot at what would seem to be the pros and cons:
Pros:
-Quick wound recovery time.
-So far 50 out of 50 survivors, but it is still early
Cons:
-About 2.5 years of experience and patient outcome data.
-Limited access in the event that a more involved procedure is called for. Personally, I'm glad that I did not have this procedure, because once my surgeon got his eyes on my aorta, he made a judegment call to replace it, as it appeared to be the tissue type that would potentially have an aneurysm later down the road. I'm glad that he made this call and it could not have happened in an operation such as this.
Although I would not choose this operation myself, I can certainly see the appeal. It will probably be a few years before the risks of operation are known and how that compares to OHS SAVR. Ultimately, one would expect that the outcomes would be similar long term, as you end up with the same piece of equipment attached to your heart. The long term issues should be the same- either reoperation or warfarin management. Once a few thousand have been performed there should be a better idea of how surgical outcomes compare to standard SAVR with OHS in the short term and eventually we will have long term data.
As has been the case with TAVR, regardless of limited data, I predict that they will have no shortage of volunteers given the appeal of a quicker surgical recovery.
@priley please share with us the outcome of your consult with Dr. Badhwar. This is very interesting.